Pacgenomics
PacGenomics: A CLIA-certified lab specializing in microarray-based genetic screening since 2011.
Founded
2011PacGenomics: A CLIA-certified lab specializing in microarray-based genetic screening since 2011.
Founded in 2011, PacGenomics is a CLIA-certified and CAP-accredited clinical genetics laboratory specializing in microarray-based Preimplantation Genetic Screening (PGS). The company emerged from a collaboration between PGD Science and several pioneers in genetic testing technologies. PacGenomics offers a range of services including infectious disease tests, clinical toxicology, ultra-high throughput sequencing, DNA identity testing, and reproductive genetic testing. Their core mission is to advance genetic screening technologies to improve patient outcomes and healthcare quality.
PacGenomics has established itself as a global leader in reproductive genetic testing. The company’s notable affiliations include partnerships with world-renowned experts in microarray-based and Next-Generation Sequencing testing. Key achievements include the development of sophisticated, sensitive, and specific diagnostic tools that have significantly impacted the field of genetic screening. Through their innovative services, PacGenomics has contributed to advancements in personalized medicine and improved diagnostic accuracy, making a substantial impact on both clinical practices and patient care worldwide.
Companies similar to Pacgenomics include Pathway Genomics, Allelica, Cradle Genomics and Genomic Prediction.
Pacgenomics was founded in 2011.
Pacgenomics' headquarters is located in Agoura Hills, CA, US.
Pacgenomics' most recent funding round was for $3M (USD) in January 2015.
As of Jan 12, 2015, Pacgenomics has disclosed funding of $4.5M (USD). Undisclosed round amounts are excluded.
Pacgenomics has 7 employees as of Feb 5, 2024.
